Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000086 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 3, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
15,000
Total Value
$1,315,346.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 1, 2026 | Sale | 10,176 | $87.44 | $889,789.44 | 587,364 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 4,234 | $88.12 | $373,100.08 | 583,130 | Direct | โ | View Details | |
Director | Common Stock | โ | Jul 1, 2026 | Sale | 590 | $88.91 | $52,456.90 | 582,540 | Direct | โ | View Details |